Anzeige
Mehr »
Login
Samstag, 20.04.2024 Börsentäglich über 12.000 News von 689 internationalen Medien
Goldaktie: Eine Erfolgsgeschichte, die seinesgleichen sucht, startet gerade richtig durch!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
155 Leser
Artikel bewerten:
(0)

Alphaform Produces Hip Implants Using EOS Additive Manufacturing

SHANGHAI, September 10, 2015 /PRNewswire/ --

15-Year-old cancer patient receives the perfect implant and renewed hope for the future

- Cross reference: Picture is available via epa european pressphoto agency (http://www.epa.eu) -

A cancer diagnosis always comes as a shock. In the case of a boy from Croatia this was particularly true as an aggressive form of bone cancer had destroyed the teenager's hip. The only option for the doctors treating him was a complete reconstruction of the hip bone. The 3D printing experts at Alphaform, a company with extensive experience in the medical sector, successfully produced the implant relying on industrial 3D Printing from EOS, the global technology and quality leader for high-end Additive Manufacturing (AM) solutions.

The surgeon's challenge: the 15-year-old patient from Croatia had a primary bone tumor, as such not formed by metastasis and lying directly on the bone. The malignancies generally grow destructively, meaning that the original tissue must be removed. A complete arthroplasty of the hip was the fundamental prerequisite for ensuring the cancer cells did not continue to spread in the boy's body. An intervention of this type limits the mobility of the joint, and thus the mobility of the patient. With a precision implant, a patient's motor skills can largely remain unaffected in the future. In the hip area, the precise shaping of the replacement bone is particularly important.

In addition to the pure destructive force of the cancer, time was crucial because the illness was spreading with speed. The new implant also had to meet the doctors' weight specifications. The Croatian surgical team ordered an implant from Alphaform that had to be delivered fast and needed to be lightweight, yet precise. Christoph Erhardt, Director of Additive Manufacturing at Alphaform AG adds: "The design process was a real challenge. We received the complete 3D data including the cavities from Instrumentaria. Based on this we were able to start with the precise manufacture of the implant."

The implant was produced within one week on the EOSINT M 280 using a stable yet light titanium alloy. The process, from the initial computer sketches to the final implant, took only six weeks. This period included the sophisticated finishing of the artificial bone.

The subsequent operation in May 2014 was a great success. First the team of doctors completely removed all of the parts affected by the cancer and then the new artificial hip was inserted, complete with the integrated joint. A part of the young patient's thigh was replaced so that both joint parts fit within one another perfectly. As such, all medical requirements for the implant were fulfilled and laid the foundation for the patient's successful recovery.

Please find the complete English case story here. For further information please contact Stephanie Cheong, Marketing Manager EOS Singapore Pte. Ltd. (phone +65-6430-0541, e-Mail: Stephanie.cheong@eos.info).

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2015 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.